Next, multicolor flow cytometry was used to evaluate the percentage of cells that were positive for CD24, CD44, EpCAM, CD133, and their combinations in three tumor-derived cell lines (Fig 2; Table 3). This evidence concerns the gene PROM1 and neoplasm.